{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T02:51:43Z","timestamp":1789095103728,"version":"build-2803163510"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002977","name":"Dalhousie University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002977","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002977","name":"Dalhousie University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002977","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004054","name":"King Abdul Aziz University, Jeddah, Saudi Arabia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.coph.2016.10.005","type":"journal-article","created":{"date-parts":[[2016,11,9]],"date-time":"2016-11-09T09:30:55Z","timestamp":1478683855000},"page":"32-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"special_numbering":"C","title":["Cannabinoid receptor ligand bias: implications in the central nervous system"],"prefix":"10.1016","volume":"32","author":[{"given":"Robert B","family":"Laprairie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amina M","family":"Bagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen M","family":"Denovan-Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2016.10.005_bib0385","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1369-1600.2008.00108.x","article-title":"Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond","volume":"13","author":"Pertwee","year":"2008","journal-title":"Addict Biol"},{"key":"10.1016\/j.coph.2016.10.005_sbref0390","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1124\/mol.115.101980","article-title":"Biased type 1 cannabinoid receptor signaling influences neuronal viability in a cell culture model of Huntington disease","volume":"89","author":"Laprairie","year":"2016","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.coph.2016.10.005_bib0395","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S0026-895X(25)09729-9","article-title":"Cannabinoid receptor binding and agonist activity of amides and esters of arachidonic acid","volume":"46","author":"Pinto","year":"1994","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.coph.2016.10.005_bib0400","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/0014-5793(95)01207-U","article-title":"The peripheral cannabinoid receptor: adenylate cyclase inhibition and G protein coupling","volume":"375","author":"Bayewitch","year":"1995","journal-title":"FEBS Lett"},{"key":"10.1016\/j.coph.2016.10.005_bib0405","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1042\/bj3120637","article-title":"Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1","volume":"312","author":"Bouaboula","year":"1995","journal-title":"Biochem J"},{"key":"10.1016\/j.coph.2016.10.005_bib0410","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/0014-2999(95)00318-F","article-title":"Pharmacological characterization of three novel cannabinoid receptor agonists in the mouse isolated vas deferens","volume":"284","author":"Pertwee","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.coph.2016.10.005_bib0415","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0026-895X(25)10492-6","article-title":"Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors","volume":"48","author":"Felder","year":"1995","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.coph.2016.10.005_bib0420","article-title":"Endocannabionoid system in neurological disorders","author":"Bifulco","year":"2016","journal-title":"Recent Pat CNS Drug Discov"},{"key":"10.1016\/j.coph.2016.10.005_bib0425","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0026-895X(25)10492-6","article-title":"Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors","volume":"48","author":"Felder","year":"1995","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.coph.2016.10.005_bib0430","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.bbrc.2006.06.175","article-title":"Identification of N-arachidonylglycine as the endogenous ligand for orphan G-protein-coupled receptor GPR18","volume":"347","author":"Kohno","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.coph.2016.10.005_bib0435","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1096\/fasebj.29.1_supplement.772.7","article-title":"Biased signalling might be the answer to the inconsistent pharmacology of GPR55","volume":"29","author":"Zeng","year":"2015","journal-title":"FASEB J"},{"key":"10.1016\/j.coph.2016.10.005_sbref0440","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1124\/jpet.116.232561","article-title":"Functional selectivity of CB2 cannabinoid receptor ligands at a canonical and noncanonical pathway","volume":"358","author":"Dhopeshwarkar","year":"2016","journal-title":"Pharmacol Exp Ther"},{"key":"10.1016\/j.coph.2016.10.005_sbref0445","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nrd3954","article-title":"Signalling bias in new drug discovery: detection, quantification and therapeutic impact","volume":"12","author":"Kenakin","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.coph.2016.10.005_bib0450","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1124\/jpet.110.173948","article-title":"Functional selectivity and biased receptor signaling","volume":"336","author":"Kenakin","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.coph.2016.10.005_sbref0455","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.tips.2014.04.007","article-title":"Biased ligands at G-protein-coupled receptors: promise and progress","volume":"35","author":"Violin","year":"2014","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.coph.2016.10.005_bib0460","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.biopsych.2011.11.027","article-title":"\u03b2-Arrestin2 regulates cannabinoid CB1 receptor signaling and adaptation in a central nervous system region-dependent manner","volume":"71","author":"Nguyen","year":"2012","journal-title":"Bio Psychiatry"},{"key":"10.1016\/j.coph.2016.10.005_bib0465","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.tips.2015.05.008","article-title":"Functional studies cast light on receptor states","volume":"36","author":"Ehlert","year":"2015","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.coph.2016.10.005_bib0470","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/mol.109.060251","article-title":"Ligand- and heterodimer-directed signaling of the CB(1) cannabinoid receptor","volume":"77","author":"Hudson","year":"2010","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.coph.2016.10.005_bib0475","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1124\/mol.114.096503","article-title":"A novel method for analyzing extremely biased agonism at G protein-coupled receptors","volume":"87","author":"Stahl","year":"2015","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.coph.2016.10.005_sbref0480","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1098\/rspb.1983.0093","article-title":"Operational models of pharmacological agonism","volume":"220","author":"Black","year":"1983","journal-title":"Proc R Soc Lond B Biol Sci"},{"key":"10.1016\/j.coph.2016.10.005_bib0485","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1006\/jmcc.2002.2020","article-title":"Subtype specific roles of \u03b2-adrenergic receptors in apoptosis of adult rat ventricular myocytes","volume":"34","author":"Shizukuda","year":"2002","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.coph.2016.10.005_bib0490","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1126\/science.286.5449.2495","article-title":"Enhanced morphine analgesia in mice lacking beta-arrestin 2","volume":"286","author":"Bohn","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.coph.2016.10.005_bib0495","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1124\/mol.56.6.1362","article-title":"Agonist selective regulation of G proteins by cannabinoid CB1 and CB2 receptors","volume":"56","author":"Glass","year":"1999","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.coph.2016.10.005_bib0500","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1124\/mol.104.003558","article-title":"Chemically distinct ligands promote differential CB1 cannabinoid receptor-Gi protein interactions","volume":"67","author":"Mukhopadhyay","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.coph.2016.10.005_bib0505","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/bjp.2008.230","article-title":"Differential modulation of AP-1- and CRE-driven transcription by cannabinoid agonists emphasizes functional selectivity at the CB1 receptor","volume":"155","author":"Bosier","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.coph.2016.10.005_bib0510","doi-asserted-by":"publisher","first-page":"3861","DOI":"10.1016\/j.febslet.2008.10.022","article-title":"Reciprocal influences of CB1 cannabinoid receptor agonists on ERK and JNK signalling in N1E-115 cells","volume":"582","author":"Bosier","year":"2008","journal-title":"FEBS Lett"},{"key":"10.1016\/j.coph.2016.10.005_bib0515","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1111\/j.1471-4159.2007.04679.x","article-title":"Agonist selective modulation of tyrosine hydroxylase expression by cannabinoid ligands in a murine neuroblastoma cell line","volume":"102","author":"Bosier","year":"2007","journal-title":"J Neurochem"},{"key":"10.1016\/j.coph.2016.10.005_bib0520","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1016\/j.neuropharm.2012.02.003","article-title":"Differential modulations of striatal tyrosine hydroxylase and dopamine metabolism by cannabinoid agonists as evidence for functional selectivity in vivo","volume":"62","author":"Bosier","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.coph.2016.10.005_bib0525","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.neuropharm.2010.07.005","article-title":"Revisiting the complex influences of cannabinoids on motor functions unravels pharmacodynamic differences between cannabinoid agonists","volume":"59","author":"Bosier","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.coph.2016.10.005_bib0530","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.bcp.2008.10.010","article-title":"Concomitant activation of adenylyl cyclase suppresses the opposite influences of CB(1) cannabinoid receptor agonists on tyrosine hydroxylase expression","volume":"77","author":"Bosier","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.coph.2016.10.005_bib0535","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1038\/sj.bjp.0701101","article-title":"Paradoxical action of the cannabinoid WIN 55,212-2 in stimulated and basal cyclic AMP accumulation in rat globus pallidus slices","volume":"120","author":"Maneuf","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.coph.2016.10.005_bib0540","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0022-3565(24)37189-7","article-title":"LY320135, a novel cannabinoid CB1 receptor antagonist, unmasks coupling of the CB1 receptor to stimulation of cAMP accumulation","volume":"284","author":"Felder","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.coph.2016.10.005_bib0545","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0022-3565(24)37876-0","article-title":"Dual activation and inhibition of adenylyl cyclase by cannabinoid receptor agonists: evidence for agonist-specific trafficking of intracellular responses","volume":"287","author":"Bonhaus","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.coph.2016.10.005_bib0550","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/S0014-2999(99)00349-0","article-title":"Dual intracellular signaling pathways mediated by the human cannabinoid CB1 receptor","volume":"374","author":"Calandra","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.coph.2016.10.005_sbref0555","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1124\/mol.115.103176","article-title":"Mechanisms of biased \u03b2-arrestin-mediated signaling downstream from the cannabinoid 1 receptor","volume":"89","author":"Delgado-Peraza","year":"2016","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.coph.2016.10.005_bib0560","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1177\/1087057109333101","article-title":"Beta-arrestin-based Bret2 screening assay for the \u201cnon\u201d-beta-arrestin binding CB1 receptor","volume":"14","author":"Vrecl","year":"2009","journal-title":"J Biomol Screen"},{"key":"10.1016\/j.coph.2016.10.005_bib0565","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1046\/j.1471-4159.1999.0722032.x","article-title":"Involvement of the carboxyl terminus of the third intracellular loop of the cannabinoid CB1 receptor in constitutive activation of Gs","volume":"72","author":"Abadji","year":"1999","journal-title":"J Neurochem"},{"key":"10.1016\/j.coph.2016.10.005_bib0570","doi-asserted-by":"crossref","first-page":"5327","DOI":"10.1523\/JNEUROSCI.17-14-05327.1997","article-title":"Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor","volume":"17","author":"Glass","year":"1997","journal-title":"J Neurosci"},{"key":"10.1016\/j.coph.2016.10.005_bib0575","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1124\/mol.116.103465","article-title":"Antagonism of dopamine receptor 2 long affects cannabinoid receptor 1 signaling in a cell culture model of striatal medium spiny projection neurons","volume":"89","author":"Bagher","year":"2016","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.coph.2016.10.005_bib0580","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1177\/1087057108330115","article-title":"Evaluating cellular impedance assays for detection of GPCR pleiotropic signaling and functional selectivity","volume":"14","author":"Peters","year":"2009","journal-title":"J Biomol Screen"},{"key":"10.1016\/j.coph.2016.10.005_bib0585","doi-asserted-by":"publisher","first-page":"19144","DOI":"10.1073\/pnas.0509588102","article-title":"The cannabinoid agonist WIN55,212-2 increases intracellular calcium via CB1 receptor coupling to Gq\/11 G proteins","volume":"102","author":"Lauckner","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coph.2016.10.005_bib0590","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1038\/sj.bjp.0707495","article-title":"Agonist-dependent cannabinoid receptor signalling in human trabecular meshwork cells","volume":"152","author":"McIntosh","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.coph.2016.10.005_bib0595","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/bph.13341","article-title":"Identification of N-arachidonoyl dopamine as a highly biased ligand at cannabinoid CB1 receptors","volume":"173","author":"Redmond","year":"2016","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.coph.2016.10.005_bib0600","doi-asserted-by":"publisher","first-page":"24845","DOI":"10.1074\/jbc.M114.557025","article-title":"Type 1 cannabinoid receptor ligands display functional selectivity in a cell culture model of striatal medium spiny projection neurons","volume":"289","author":"Laprairie","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coph.2016.10.005_bib0605","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.chemphyslip.2013.01.009","article-title":"Endogenous lipid activated G protein-coupled receptors: emerging structural features from crystallography and molecular dynamics simulations","volume":"169","author":"Hurst","year":"2013","journal-title":"Chem Phys Lipids"},{"key":"10.1016\/j.coph.2016.10.005_bib0610","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/j.cellsig.2013.03.020","article-title":"CB1 cannabinoid receptors promote maximal FAK catalytic activity by stimulating cooperative signaling between receptor tyrosine kinases and integrins in neuronal cells","volume":"25","author":"Dalton","year":"2013","journal-title":"Cell Signal"},{"key":"10.1016\/j.coph.2016.10.005_bib0615","doi-asserted-by":"publisher","first-page":"4589","DOI":"10.1038\/ncomms5589","article-title":"Ligand-specific endocytic dwell times control functional selectivity of the cannabinoid receptor 1","volume":"5","author":"Flores-Otero","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.coph.2016.10.005_bib0620","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1523\/JNEUROSCI.19-10-03773.1999","article-title":"Distinct domains of the CB1 cannabinoid receptor mediate desensitization and internalization","volume":"19","author":"Jin","year":"1999","journal-title":"J Neurosci"},{"key":"10.1016\/j.coph.2016.10.005_bib0625","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.neuropharm.2007.06.005","article-title":"Rapid CB1 cannabinoid receptor desensitization defines the time course of ERK1\/2 MAP kinase signaling","volume":"54","author":"Daigle","year":"2008","journal-title":"Neuropharmacol"},{"key":"10.1016\/j.coph.2016.10.005_sbref0630","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1124\/mol.115.099192","article-title":"Biased agonism and biased allosteric modulation at the CB1 cannabinoid receptor","volume":"88","author":"Khajehali","year":"2015","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.coph.2016.10.005_bib0635","doi-asserted-by":"publisher","first-page":"5979","DOI":"10.1021\/acs.jmedchem.5b00579","article-title":"Distinct temporal fingerprint for cyclic adenosine monophosphate (cAMP) signaling of indole-2-carboxamides as allosteric modulators of the cannabinoid receptors","volume":"58","author":"Cawston","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.coph.2016.10.005_bib0640","doi-asserted-by":"publisher","first-page":"10842","DOI":"10.1038\/ncomms10842","article-title":"The role of kinetic context in apparent biased agonism at GPCRs","volume":"7","author":"Herenbrink","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.coph.2016.10.005_bib0645","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1124\/jpet.105.089474","article-title":"Agonist-directed trafficking of response by endocannabinoids acting at CB2 receptors","volume":"315","author":"Shoemaker","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.coph.2016.10.005_sbref0650","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1124\/mol.111.074013","article-title":"Functional selectivity in CB2 cannabinoid receptor signaling and regulation: implications for the therapeutic potential of CB2 ligands","volume":"81","author":"Atwood","year":"2012","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.coph.2016.10.005_bib0655","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.chembiol.2011.05.012","article-title":"Mechanisms of osteoclastogenesis inhibition by a novel class of biphenyl-type cannabinoid CB2 receptor inverse agonists","volume":"18","author":"Schuehly","year":"2011","journal-title":"Chem Biol"},{"key":"10.1016\/j.coph.2016.10.005_bib0660","first-page":"12","article-title":"4\u2032-O-methylhonokiol increases levels of 2-arachidonoyl glycerol in mouse brain via selective inhibition of its COX-2-mediated oxygenation","volume":"13","author":"Chicca","year":"2015","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.coph.2016.10.005_bib0665","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1124\/mol.114.094649","article-title":"CB2 cannabinoid receptors as a therapeutic target\u2014what does the future hold?","volume":"86","author":"Dhopeshwarkar","year":"2014","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.coph.2016.10.005_bib0670","doi-asserted-by":"publisher","first-page":"3908","DOI":"10.1111\/bph.12746","article-title":"Activation of GPR18 by cannabinoid compounds: a tale of biased agonism","volume":"171","author":"Console-Bram","year":"2014","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.coph.2016.10.005_bib0675","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/nrd4052","article-title":"Emerging paradigms in GPCR allostery: implications for drug discovery","volume":"12","author":"Wootten","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.coph.2016.10.005_bib0680","series-title":"Abstract 58, International Cannabinoids Research Symposium, Wolfville, NS, CAN","author":"Laprairie","year":"2015"},{"key":"10.1016\/j.coph.2016.10.005_bib0685","doi-asserted-by":"publisher","first-page":"2948","DOI":"10.1038\/npp.2015.148","article-title":"A cannabinoid CB1 receptor-positive allosteric modulator reduces neuropathic pain in the mouse with no psychoactive effects","volume":"40","author":"Ignatowska-Jankowska","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.coph.2016.10.005_bib0690","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/brain\/awq278","article-title":"Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease","volume":"134","author":"Bl\u00e1zquez","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.coph.2016.10.005_bib0695","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.nbd.2011.03.006","article-title":"Worsening of Huntington disease phenotype in CB1 receptor knockout mice","volume":"42","author":"Mievis","year":"2011","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.coph.2016.10.005_bib0700","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/ejn.12045","article-title":"Downregulation of cannabinoid receptor 1 from neuropeptide Y interneurons in the basal ganglia of patients with Huntington's disease and mouse models","volume":"37","author":"Horne","year":"2013","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.coph.2016.10.005_bib0705","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.ejmg.2013.05.007","article-title":"CNR1 variation is associated with the age at onset in Huntington disease","volume":"56","author":"Kloster","year":"2013","journal-title":"Eur J Med Genet"},{"key":"10.1016\/j.coph.2016.10.005_bib0710","doi-asserted-by":"publisher","first-page":"8257","DOI":"10.1073\/pnas.1400988111","article-title":"A restricted population of CB1 cannabinoid receptors with neuroprotective activity","volume":"111","author":"Chiarlone","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coph.2016.10.005_bib0715","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.nbd.2014.08.009","article-title":"Genetic rescue of CB1 receptors on medium spiny neurons prevents loss of excitatory striatal synapses but not motor impairment in HD mice","volume":"71","author":"Naydenov","year":"2014","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.coph.2016.10.005_bib0720","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1038\/cdd.2015.11","article-title":"The CB1 cannabinoid receptor signals striatal neuroprotection via a PI3K\/Akt\/mTORC1\/BDNF pathway","volume":"22","author":"Bl\u00e1zquez","year":"2015","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.coph.2016.10.005_bib0725","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/384083a0","article-title":"Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides","volume":"384","author":"Cravatt","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.coph.2016.10.005_bib0730","doi-asserted-by":"publisher","first-page":"10819","DOI":"10.1073\/pnas.152334899","article-title":"Brain monoglyceride lipase participating in endocannabinoid inactivation","volume":"99","author":"Dinh","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coph.2016.10.005_bib0735","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.neuroscience.2010.06.056","article-title":"Behavioural and molecular consequences of chronic cannabinoid treatment in Huntington's disease transgenic mice","volume":"170","author":"Dowie","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.coph.2016.10.005_bib0740","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1111\/j.1476-5381.2011.01744.x","article-title":"Differential signalling in human cannabinoid CB1 receptors and their splice variants in autaptic hippocampal neurones","volume":"165","author":"Straiker","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.coph.2016.10.005_bib0745","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejphar.2004.09.058","article-title":"Species comparison and pharmacological characterization of rat and human CB2 cannabinoid receptors","volume":"505","author":"Mukherjee","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.coph.2016.10.005_bib0750","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/sj.bjp.0707303","article-title":"Species-specific in vitro pharmacological effects of the cannabinoid receptor 2 (CB2) selective ligand AM1241 and its resolved enantiomers","volume":"151","author":"Bingham","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.coph.2016.10.005_bib0755","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1002\/jcc.21794","article-title":"Parameterization of Org27569: an allosteric modulator of the cannabinoid CB1 G protein-coupled receptor","volume":"32","author":"Iliff HA1","year":"2011","journal-title":"J Comput Chem"},{"key":"10.1016\/j.coph.2016.10.005_bib0760","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1021\/acschemneuro.5b00090","article-title":"Molecular-interaction and signaling profiles of AM3677, a novel covalent agonist selective for the cannabinoid 1 receptor","volume":"6","author":"Janero","year":"2015","journal-title":"ACS Chem Neurosci"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489216301266?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489216301266?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T05:52:10Z","timestamp":1749707530000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471489216301266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":76,"alternative-id":["S1471489216301266"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2016.10.005","relation":{},"ISSN":["1471-4892"],"issn-type":[{"value":"1471-4892","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabinoid receptor ligand bias: implications in the central nervous system","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coph.2016.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}